Position in IOVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,975,746
+$947,566 QoQ
Shares Held
474,939
+62.1% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#59
of 292 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. IOVA ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in IOVA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,975,746 | 474,939 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,028,180 | 292,929 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,184,817 | 433,999 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $935,337 | 280,882 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $417,360 | 56,400 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $507,717 | 54,070 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $282,993 | 35,286 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $574,689 | 38,778 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $976,315 | 120,088 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,791,680 | 393,776 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,480,234 | 352,306 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,535,729 | 415,013 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,501,001 | 391,393 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,292,387 | 343,673 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,819,447 | 164,805 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $795,503 | 47,778 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $694,398 | 36,375 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $834,445 | 33,838 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $349,969 | 13,450 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $539,214 | 11,621 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $844,279 | 30,757 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,501,461 | 50,149 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||